Stay updated on Lomvastomig in Solid Tumors Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.

Latest updates to the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check11 days agoChange DetectedThe ClinicalTrials.gov site revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe history table adds an entry for Revision: v3.7.0 and removes Revision: v3.6.6, reflecting an update to the page's revision-tracking rather than changes to the study data.SummaryDifference0.1%

- Check53 days agoChange DetectedThe history list now shows a new revision tag (v3.6.6) for the record, replacing the former v3.6.5 entry and indicating an update to the page’s version history.SummaryDifference0.1%

- Check74 days agoChange DetectedThe record history shows a new Revision: v3.6.5 entry, replacing the previous v3.6.4.SummaryDifference0.1%

- Check89 days agoChange DetectedThe page's revision marker was updated to v3.6.4, replacing the previous v3.6.3.SummaryDifference0.1%

Stay in the know with updates to Lomvastomig in Solid Tumors Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.